Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Phase I Drug Development, Solid Tumors

Amita Patnaik

MBBS

🏢South Texas Accelerated Research Therapeutics🌐USA

Director, Drug Development Program

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Amita Patnaik at START San Antonio leads one of the premier phase I oncology programs in the US. Her extensive experience conducting first-in-human studies of novel oncology agents across all histologies, her expertise in phase I trial design and pharmacology, and her track record of progressing multiple molecules through early development to approval has made the START program a hub for industry-sponsored phase I oncology research.

Share:

🧪Research Fields 研究领域

START phase I program
solid tumor phase I
novel agent combination phase I
immune oncology early phase
clinical pharmacology phase I

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Amita Patnaik 的研究动态

Follow Amita Patnaik's research updates

留下邮箱,当我们发布与 Amita Patnaik(South Texas Accelerated Research Therapeutics)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment